We found that TLR4/MyD88 signaling in liver parenchymal cells plays a pivotal role during the early progression of HFD-induced nonalcoholic fatty liver disease (NAFLD), in which free HMGB1 served as a positive component mediating TLR4 activation12. This evidence concerns the gene MYD88 and metabolic dysfunction-associated steatotic liver disease.